6GEG image
Entry Detail
PDB ID:
6GEG
Keywords:
Title:
TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) AT 2.23A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2018-04-26
Release Date:
2018-09-19
Method Details:
Experimental Method:
Resolution:
2.23 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Transcriptional enhancer factor TEF-3
Mutations:Y429F
Chain IDs:A
Chain Length:219
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Transcriptional coactivator YAP1
Mutations:S94A
Chain IDs:B (auth: L)
Chain Length:41
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface.
Protein Sci. 27 1810 1820 (2018)
PMID: 30058229 DOI: 10.1002/pro.3493

Abstact

Many interactions between proteins are mediated by intrinsically disordered regions (IDRs). Intrinsically disordered proteins (IDPs) do not adopt a stable three-dimensional structure in their unbound form, but they become more structured upon binding to their partners. In this communication, we study how a bound IDR adapts to mutations, preventing the formation of hydrogen bonds at the binding interface that needs a precise positioning of the interacting residues to be formed. We use as a model the YAP:TEAD interface, where one YAP (IDP) and two TEAD residues form hydrogen bonds via their side chain. Our study shows that the conformational flexibility of bound YAP and the reorganization of water molecules at the interface help to reduce the energetic constraints created by the loss of H-bonds at the interface. The residual flexibility/dynamic of bound IDRs and water might, therefore, be a key for the adaptation of IDPs to different interface landscapes and to mutations occurring at binding interfaces.

Legend

Protein

Chemical

Disease

Primary Citation of related structures